Potential to modulate corneal epithelial repair via nitric oxide-releasing glycosaminoglycans.
4 affiliations
- 1Department of Chemistry, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA [email protected].
- 2Department of Oral Biology, College of Dentistry, University of Florida Gainesville FL 32610 USA.
- 3Department of Surgery, College of Medicine, University of Florida Gainesville FL 32610 USA.
- 4Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA.
Abstract
Bioactive wound therapies that protect injured tissue, promote regeneration, and prevent infection would represent a promising alternative to traditional passive treatments. In this study, nitric oxide (NO)-releasing glycosaminoglycans (GAGs) were synthesized and evaluated for their therapeutic potential in corneal wound healing. Low and high molecular weight hyaluronic acid (HA) and chondroitin sulfate (CS) derivatives of different sulfation patterns were synthesized and characterized with respect to NO release, antibacterial activity, cytotoxicity, and effects on human corneal epithelial cell proliferation and migration. A three-dimensional corneal tissue scratch closure model was subsequently used to assess in vitro barrier restoration. A derivative consisting of CS with prolonged NO release and low molecular weight HA with intermediate NO-release kinetics were identified as the most promising materials. The HA derivative enhanced epithelial migration even during later timepoints of the migration assays. A carboxymethylcellulose (CMC) gel formulation containing the HA derivative further promoted cell migration. In corneal tissue models, treatment with both the free and CMC-formulated NO-releasing HA enhanced restoration. Barrier recovery, as measured by transepithelial electrical resistance, confirmed restoration of tissue integrity post-wounding, concomitant with a cytokine milieu associated with pro-wound healing. Overall, NO-releasing, low molecular weight HA in a CMC gel formulation represents a promising bioactive strategy for promoting corneal wound repair.
Related
- Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endothelium
- Microcystic epithelial keratopathy associated with mirvetuximab soravtansine therapy: Multimodal corneal imaging and refractive changes
- Optimization of culture conditions for the human corneal epithelial cell line IM-HCEpiC and evaluation of its extracellular vesicles in repair
- Recurrent Corneal Erosion Syndrome in Epithelial Basement Membrane Dystrophy: Current Treatments and Mechanism-Guided Therapeutic Opportunities
- Corneal epithelial regenerative medicine: lessons from somatic stem cell therapy toward iPS cell-based regeneration.
BibTeX
@article{purvis2026potential,
title = {{Potential to modulate corneal epithelial repair via nitric oxide-releasing glycosaminoglycans.}},
author = {Margery E Purvis and Madelyn P Bucci and Tsian D Ramrattan and Shannon M Wallet and Mark H Schoenfisch},
journal = {RSC pharmaceutics},
year = {2026},
month = oct,
doi = {10.1039/d6pm00190d},
url = {https://europepmc.org/article/MED/42899131},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Potential to modulate corneal epithelial repair via nitric oxide-releasing glycosaminoglycans.
AU - Margery E Purvis
AU - Madelyn P Bucci
AU - Tsian D Ramrattan
AU - Shannon M Wallet
AU - Mark H Schoenfisch
PY - 2026
DA - 2026/10/09
JO - RSC pharmaceutics
DO - 10.1039/d6pm00190d
UR - https://europepmc.org/article/MED/42899131
AB - Bioactive wound therapies that protect injured tissue, promote regeneration, and prevent infection would represent a promising alternative to traditional passive treatments. In this study, nitric oxide (NO)-releasing glycosaminoglycans (GAGs) were synthesized and evaluated for their therapeutic potential in corneal wound healing. Low and high molecular weight hyaluronic acid (HA) and chondroitin sulfate (CS) derivatives of different sulfation patterns were synthesized and characterized with respect to NO release, antibacterial activity, cytotoxicity, and effects on human corneal epithelial cell proliferation and migration. A three-dimensional corneal tissue scratch closure model was subsequently used to assess in vitro barrier restoration. A derivative consisting of CS with prolonged NO release and low molecular weight HA with intermediate NO-release kinetics were identified as the most promising materials. The HA derivative enhanced epithelial migration even during later timepoints of the migration assays. A carboxymethylcellulose (CMC) gel formulation containing the HA derivative further promoted cell migration. In corneal tissue models, treatment with both the free and CMC-formulated NO-releasing HA enhanced restoration. Barrier recovery, as measured by transepithelial electrical resistance, confirmed restoration of tissue integrity post-wounding, concomitant with a cytokine milieu associated with pro-wound healing. Overall, NO-releasing, low molecular weight HA in a CMC gel formulation represents a promising bioactive strategy for promoting corneal wound repair.
SN - 2976-8713
ER -